You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

Drug Price Trends for INDERAL XL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for INDERAL XL

Average Pharmacy Cost for INDERAL XL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
INDERAL XL 80 MG CAPSULE 62559-0600-30 69.29967 EACH 2024-12-18
INDERAL XL 120 MG CAPSULE 62559-0601-30 69.09967 EACH 2024-12-18
INDERAL XL 80 MG CAPSULE 62559-0600-30 69.28644 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for INDERAL XL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
INDERAL XL 120MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0601-30 30 1573.28 52.44267 EACH 2023-01-01 - 2027-07-14 Big4
INDERAL XL 80MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0600-30 30 1568.17 52.27233 EACH 2023-01-01 - 2027-07-14 Big4
INDERAL XL 120MG CAP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 62559-0601-30 30 2151.16 71.70533 EACH 2023-01-01 - 2027-07-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

INDERAL XL Market Analysis and Financial Projection

Market Analysis and Price Projections for Inderal XL

Overview of Inderal XL

INDERAL XL, containing propranolol hydrochloride, is a nonselective beta-adrenergic receptor-blocking agent used primarily for the treatment of hypertension. It is available in extended-release capsules of 80 mg and 120 mg, designed to provide sustained release of the active ingredient over several hours[1].

Market Context

Antihypertensive Drugs Market

The global antihypertensive drugs market is a significant segment within the pharmaceutical industry. This market includes various drug classes such as beta-blockers, angiotensin II receptor blockers, and fixed-dose combinations. The market is expected to grow due to increasing prevalence of hypertension and the need for effective management of cardiovascular diseases[3].

Beta Blockers Market

Specifically, the beta blockers market, which includes Inderal XL, was valued at USD 10.54 billion in 2023 and is projected to grow at a CAGR of 5.23% to reach USD 15.08 billion by 2030. This growth is driven by the increasing demand for beta blockers in managing hypertension and other cardiovascular conditions[4].

Market Penetration and Development

Current Market Position

INDERAL XL is a well-established brand within the beta blockers segment. It has been on the market for several years and is recognized for its efficacy in lowering blood pressure and reducing the risk of fatal and nonfatal cardiovascular events. The drug's extended-release formulation enhances patient compliance by reducing the frequency of dosing[1].

Competitive Landscape

The beta blockers market is competitive, with several other brands and generic versions available. However, Inderal XL maintains a strong position due to its established reputation and the trust of healthcare providers. The market also sees competition from other antihypertensive drug classes, but beta blockers remain a preferred option for many patients due to their proven safety and efficacy profile[4].

Pricing and Cost Analysis

Current Pricing

The cost of Inderal XL can be significant, with a supply of 30 capsules of the 80 mg or 120 mg strength costing around $2,348, depending on the pharmacy. However, generic versions of propranolol are available at a lower cost, starting from around $86.56 for 100 capsules[2].

Price Projections

Given the competitive nature of the market and the availability of generic alternatives, the prices of Inderal XL may remain stable or see a slight decrease. The generic version of propranolol is expected to continue offering a cost-effective alternative, which could influence the pricing strategy for branded products like Inderal XL.

Impact of Generic Competition

The presence of generic propranolol has a significant impact on the pricing of Inderal XL. Generic versions are often preferred by patients and healthcare providers due to their lower cost, which can lead to a reduction in market share for the branded product. However, Inderal XL's extended-release formulation and brand loyalty may help it maintain a market presence despite the competition from generics[2].

Distribution and Availability

Supply Chain

INDERAL XL is widely available in pharmacies across the U.S. and is supplied in bottles of 30 capsules, as well as in professional samples. The drug is distributed by various pharmaceutical companies, including ANI Pharmaceuticals, which has seen increased sales of Inderal XL in recent years[1][5].

Patient Assistance Programs

To make the drug more accessible, patient assistance programs and copay cards are often available. These programs can help reduce the out-of-pocket costs for patients, making Inderal XL more affordable despite its higher price compared to generic alternatives[2].

Regulatory and Market Trends

Regulatory Environment

The regulatory environment plays a crucial role in the pricing and availability of Inderal XL. Changes in regulatory policies or the approval of new antihypertensive drugs can impact the market dynamics. However, as a well-established drug, Inderal XL is less likely to face significant regulatory challenges[4].

Market Trends

The trend towards more personalized and effective treatments in hypertension management is expected to continue. This could lead to increased demand for drugs like Inderal XL that offer sustained release and improved patient compliance. Additionally, the growing awareness of cardiovascular health and the importance of blood pressure management will drive the demand for antihypertensive drugs, including beta blockers[3].

Key Takeaways

  • Market Position: Inderal XL is a well-established brand in the beta blockers segment, used for treating hypertension.
  • Pricing: The drug is priced around $2,348 for a 30-capsule supply, with generic alternatives available at a lower cost.
  • Competitive Landscape: The market is competitive with other beta blockers and antihypertensive drug classes, but Inderal XL maintains a strong position.
  • Price Projections: Prices may remain stable or see a slight decrease due to generic competition.
  • Distribution and Availability: Widely available in pharmacies and through patient assistance programs.
  • Regulatory and Market Trends: The regulatory environment and market trends favor continued demand for effective antihypertensive drugs like Inderal XL.

FAQs

What is Inderal XL used for?

INDERAL XL is used for the treatment of hypertension to lower blood pressure and reduce the risk of fatal and nonfatal cardiovascular events[1].

How much does Inderal XL cost?

The cost of Inderal XL is around $2,348 for a supply of 30 capsules, depending on the pharmacy. Generic versions are available at a lower cost, starting from around $86.56 for 100 capsules[2].

Is there a generic version of Inderal XL?

Yes, a generic version of propranolol is available, which is significantly cheaper than the branded Inderal XL[2].

What are the common side effects of Inderal XL?

Common side effects include allergic reactions, exacerbation of peripheral arterial disease, and systemic lupus erythematosus (SLE). Other adverse reactions have been reported during post-marketing use[1].

How is Inderal XL supplied?

INDERAL XL is supplied in bottles of 30 capsules and in professional samples. The 80 mg strength is a white opaque capsule, and the 120 mg strength is a buff opaque capsule[1].

What is the impact of generic competition on Inderal XL pricing?

The availability of generic propranolol can lead to a reduction in the market share and pricing of Inderal XL, as generics are often preferred due to their lower cost[2].

Sources

  1. RxList: Inderal XL Propranolol Hydrochloride Capsules.
  2. Drugs.com: Inderal XL Prices, Coupons, Copay Cards & Patient Assistance.
  3. iHealthcareAnalyst: Antihypertensive Drugs Market and Forecast 2024-2031.
  4. 360iResearch: Beta Blockers Market by Type, Application, Distribution Channel.
  5. ANI Pharmaceuticals: ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.